BenevolentAI Logo

BenevolentAI

Applies artificial intelligence to accelerate drug discovery and development.

BAI | AS

Overview

Corporate Details

ISIN(s):
LU2355630455
LEI:
2221003P54KEDC3P4Z33
Country:
United Kingdom
Address:
4-8 Maple Street, W1T 5HD London

Description

BenevolentAI is a clinical-stage company that specializes in applying artificial intelligence (AI) and machine learning to drug discovery and development. The company utilizes its proprietary technology platform, which is built upon a comprehensive knowledge graph, to analyze vast amounts of complex biomedical information. This platform is designed to generate novel biological insights, identify new therapeutic targets, and accelerate the research and development process for new medicines. By integrating advanced AI with scientific expertise, BenevolentAI aims to decipher complex disease biology and improve the efficiency and success rate of bringing new treatments to patients.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-03-25 07:00
BEN-8744 Phase 1a results FINAL APPROVED
English 201.1 KB
2024-03-20 07:00
2221003P54KEDC3P4Z33-2023-12-31-en
English 3.7 MB
2024-03-20 07:00
BenevolentAI Convening Notice 2024
English 126.5 KB
2024-03-14 07:00
BAI - Prelims 2023 FINAL LOCKED
English 884.6 KB
2024-02-09 12:24
PDMR Share Dealing Notification - JO .docx
English 72.7 KB
2024-02-09 11:15
PDMR Share Dealing Notification - JR.docx
English 71.7 KB
2024-02-09 11:04
PDMR Share Dealing Notifications - OB.docx
English 64.3 KB
2024-02-09 10:52
PDMR Initial Share Dealing Notification - MD (Acquisition of shares - 06.02.202…
English 48.9 KB
2024-02-09 10:41
PDMR Initial Share Dealing Notification - JM (Acquisition of shares - 06.02.202…
English 49.5 KB
2024-02-09 10:30
PDMR Initial Share Dealing Notification - FN (Acquisition of shares - 06.02.202…
English 48.4 KB
2024-01-24 07:00
Project Falcon_FINAL_23.01.24.docx (1)
English 118.5 KB
2023-12-27 11:07
PDMR Share Dealing Notification - OB (Acquisition of shares)pdf
English 52.6 KB
2023-12-27 10:59
PDMR Share Dealing Notification - JO (Acquisition of shares)
English 56.1 KB
2023-12-27 10:51
PDMR Share Dealing Notification - JR (Acquisition of shares)
English 48.7 KB
2023-12-27 10:43
PDMR Share Dealing Notification - FN (Acquisition of shares)pdf
English 48.6 KB

Automate Your Workflow. Get a real-time feed of all BenevolentAI filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for BenevolentAI

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for BenevolentAI via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.